Multiple Sclerosis Clinical Trials in Cleveland, Ohio

7 studies are recruiting for multiple sclerosis in Cleveland, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

   The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

   Stage

   Not phased

   Ages

   18 and older

   Site

   TG Therapeutics Investigational Trial Site, Cleveland, Ohio

   Locations

   109 in total

   Run by

   TG Therapeutics, Inc.

   See if you can join NCT06433752 on ClinicalTrials.gov

2. An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

   This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with Multiple Sclerosis.

   Stage

   Phase 1

   Ages

   18 to 60

   Site

   Research Site, Cleveland, Ohio

   Locations

   19 in total

   Run by

   AstraZeneca

   See if you can join NCT07224373 on ClinicalTrials.gov

3. Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis

   The purpose of this research study is to evaluate the effectiveness of an exercise training intervention (24-36 sessions) to improve muscle strength and endurance in the lower limbs of individuals with paralysis. Specifically, surface electrical stimulation or previously implanted stimulator will b…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio

   Run by

   Louis Stokes VA Medical Center

   See if you can join NCT07768761 on ClinicalTrials.gov

4. Understanding and Enhancing Human Health and Movement

   By doing this study, investigators hope to learn how electrical stimulation can improve human movement, biomechanics, and function and to gather information on the safety and effectiveness of an implanted electrical stimulation system after paralysis from spinal cord injury, stroke, multiple sclero…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio

   Run by

   Louis Stokes VA Medical Center

   See if you can join NCT07738978 on ClinicalTrials.gov

5. Care in Multiple Sclerosis (MS)

   This study is structured around three main aims. In Aim 1, investigators will conduct community-based participatory research (CBPR) to develop culturally tailored methods to assess childhood adversity in multiple sclerosis (MS). Aim 2 will investigate the impact of childhood adversity on MS outcome…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Cleveland Clinic, Cleveland, Ohio

   Locations

   6 in total

   Run by

   NYU Langone Health

   See if you can join NCT07011914 on ClinicalTrials.gov

6. Central Vein Sign in Multiple Sclerosis Extension Study

   Multiple sclerosis (MS) is a common disease of the central nervous system that affects almost 1 million people in the United States. However, diagnosing MS can be difficult and often leads to misdiagnosis. More sensitive and specific biomarkers are needed to help with the diagnosis, prognosis, and …

   Stage

   Not phased

   Ages

   18 to 65

   Site

   Cleveland Clinic Foundation, Cleveland, Ohio

   Locations

   3 in total

   Run by

   The Cleveland Clinic

   See if you can join NCT07424027 on ClinicalTrials.gov

7. Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

   The purpose of this research is to support the clinical value of the Cionic Neural Sleeve for individuals diagnosed with multiple sclerosis (MS).

   Stage

   Not phased

   Ages

   22 to 75

   Site

   Cleveland State University, Cleveland, Ohio

   Run by

   Cionic, Inc.

   See if you can join NCT05964829 on ClinicalTrials.gov